首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Requirement for nitric oxide activation of p21~ras/extracellular regulated kinase in neuronal ischemic preconditioning
【24h】

Requirement for nitric oxide activation of p21~ras/extracellular regulated kinase in neuronal ischemic preconditioning

机译:一氧化氮激活p21〜ras /细胞外调节激酶在神经元缺血预处理中的要求

获取原文
获取原文并翻译 | 示例
           

摘要

The mechanisms underlying neuronal ischemic preconditioning, a phenomenon in which brief episodes of ischemia protect against the lethal effects of subsequent periods of prolonged ischemia, are poorly understood. lschemia can be modeled in vitro by oxygen- glucose deprivation (OGD). We report here that OGD precondi- tioning induces p21~ras (Ras) activation in an N-methyl-D-aspartate receptor- and NO-dependent, but cGMP-independent. manner. We demonstrate that Ras activity is necessary and sufficient for OGD tolerance in neurons. Pharmacological inhibition of Ras, as well as a dominant negative mutant Ras. block OGD preconditioning whereas a constitutively active form of Ras promotes neuropro- tection against lethal OGD insults. In contrast. the activity of phosphatidyl inositol 3-kinase is not required for OGD precondi- tioning because inhibition of phosphatidyl inositol 3-kinase with a chemical inhibitor or with a dominant negative mutant does not have any effect on the development of OGD tolerance. Further- more, using recombinant adenoviruses and pharmacological inhib- itors. we show that downstream of Ras the extracellular regulated kinase cascade is required for OGD preconditioning. Our observa- tions indicate that activation of the Ras/extracellular regulated kinase cascade by NO is a critical mechanism for the development of OGD tolerance in cortical neurons, which may also play an important role in ischemic preconditioning in vivo.
机译:对神经元缺血预处理的机制了解甚少,在这种现象中,短暂的缺血发作可防止随后的长时间缺血的致死作用。可以通过氧-葡萄糖剥夺(OGD)在体外模拟缺血。我们在这里报告说,OGD预处理在N-甲基-D-天冬氨酸受体和NO依赖性但cGMP依赖性的诱导p21〜ras(Ras)活化。方式。我们证明,Ras活性对于神经元对OGD的耐受性是必要且足够的。 Ras以及显性负突变Ras的药理抑制作用。阻断OGD预处理,而组成型活性形式的Ras可以促进对致命OGD损伤的神经保护。相反。 OGD预处理不需要磷脂酰肌醇3激酶的活性,因为用化学抑制剂或显性负突变抑制磷脂酰肌醇3激酶对OGD耐受性的发展没有任何影响。此外,使用重组腺病毒和药理抑制剂。我们显示,在Ras下游,OGD预处理需要细胞外调节激酶级联反应。我们的观察结果表明,NO激活Ras /细胞外调节激酶级联反应是皮层神经元对OGD耐受性发展的关键机制,这在体内缺血预处理中也可能起重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号